Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898432-07-000462
Filing Date
2007-06-07
Accepted
2007-06-07 12:17:54
Documents
1
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 andreeff_form5ex.html 5  
1 andreeff_form5ex.xml 5 45362
  Complete submission text file 0000898432-07-000462.txt   47451
Mailing Address 2131 PALOMAR ROAD SUITE 300 CARLSBAD CA 92011
Business Address 2131 PALOMAR ROAD SUITE 300 CARLSBAD CA 92011 760-602-8422
Ardea Biosciences, Inc./DE (Issuer) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL ST STE 2105 BATON ROUGE LA 70801
Business Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL STREET STE 2105 BATON ROUGE LA 70801 2253447780
ANDREEFF DANE (Reporting) CIK: 0001201810 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-29993 | Film No.: 07906053